| ASSET | MONTH | % RETURN |
|---|---|---|
Eli Lilly and (LLY) | April 2023 | 15.33% |
Facebook (META) | April 2023 | 15.07% |
Novartis AG ADR (NVS) | April 2023 | 11.09% |
Abbott Laboratories (ABT) | April 2023 | 10.14% |
Merck (MRK) | April 2023 | 8.99% |
Applovin (APP) | April 2023 | 8.83% |
Micron Technology (MU) | April 2023 | 7.82% |
Berkshire Hathaway (BRK.A) | April 2023 | 7.25% |
JPMorgan Chase (JPM) | April 2023 | 7.25% |
Microsoft (MSFT) | April 2023 | 7.24% |
SAP SE ADR (SAP) | April 2023 | 7.2% |
Berkshire Hathaway (BRK.B) | April 2023 | 6.24% |
Procter & Gamble (PG) | April 2023 | 6.02% |
Wells Fargo (WFC) | April 2023 | 5.94% |
Johnson & Johnson (JNJ) | April 2023 | 5.65% |
Novo Nordisk A-S (NVO) | April 2023 | 5.52% |
AstraZeneca PLC ADR (AZN) | April 2023 | 5.31% |
Goldman Sachs (GS) | April 2023 | 5.3% |
McDonald’s (MCD) | April 2023 | 5.25% |
Mastercard (MA) | April 2023 | 4.97% |
Alphabet Inc Class A (GOOGL) | April 2023 | 4.83% |
LIN TV (LIN) | April 2023 | 4.53% |
Exxon Mobil (XOM) | April 2023 | 4.37% |
HSBC Holdings PLC ADR (HSBC) | April 2023 | 3.89% |
Royal Bank of Canada (RY) | April 2023 | 3.66% |
Mega-cap stocks are treated as having a market cap of $200B+.
